Influence of Disease Activity and Angioedema on EQ-5D-5L Utility Scores in Chronic Spontaneous Urticaria

Author(s)

Hawe E1, Simou E2, Balp MM3, Kohli R4, Wiyani A5
1RTI Health Solutions, Manchester, LAN, UK, 2RTI Health Solutions, Manchester, LAN, Great Britain, 3Novartis Pharma AG, Basel, BS, Switzerland, 4Novartis Healthcare Private Ltd., Hyderabad, India, 5Novartis Pharmaceuticals UK Limited, London, UK

OBJECTIVES: Chronic spontaneous urticaria (CSU) is a dermatological condition characterized by spontaneous occurrence of itchy hives and/or angioedema for ≥ 6 weeks. Five disease activity (health) states were previously defined. EQ-5D may not capture overall negative disease impact. This study assessed the EQ-5D-5L utility scores associated with health states and with angioedema in CSU.

METHODS: Pooled data came from two 52-week, phase 3, randomized controlled trials in adults with CSU (PEARL 1 & 2). Health status was assessed with EQ-5D-5L completed at baseline and every 4 weeks and also triggered by angioedema occurrence. Utility scores were estimated using UK tariffs. Disease activity was measured daily with Urticaria Activity Score (UAS); weekly (UAS7) scores were utilized to define health states, severe activity (UAS7 = 28-42), moderate (16-27), mild (7-15), well-controlled (1-6), urticaria-free (UAS7=0). A mixed model using visit and event driven data for adults was fit with utilities at follow-up as dependent variable; covariates included health state and angioedema status at visit. Marginal means (95% CIs) are reported by health state and angioedema status.

RESULTS: Data from 1,902 patients, mean (SD) age 42.7 (13.5) years, 71.4% female were used. For those without angioedema, mean (95% CI) utility scores for each health state from severe to urticaria‑free were 0.713 (0.703-0.723), 0.812 (0.802-0.821), 0.869 (0.861-0.878), 0.907 (0.898-0.916), 0.930, (0.922-0.937) respectively and for those with angioedema, were 0.621 (0.612-0.631), 0.720 (0.710-0.730), 0.778 (0.768-0.788), 0.815 (0.804-0.827), and 0.838 (0.827-0.849), respectively. Based on the model, for all health states, utility scores are predicted to be lower by a mean of 0.092 for those with angioedema compared to without.

CONCLUSIONS: This analysis shows that, by using enhanced collection of EQ-5D-5L, linked to occurrence of specific events (e.g angioedema), the negative impact on health status is captured. Higher disease activity and angioedema were associated with lower utility scores.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

PCR260

Topic

Patient-Centered Research

Topic Subcategory

Health State Utilities

Disease

No Additional Disease & Conditions/Specialized Treatment Areas, Sensory System Disorders (Ear, Eye, Dental, Skin)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×